Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including kickbacks, billing fraud, ...

EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...

Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came after activist short seller Scorpion Capital released a scathing report ...

Activist short seller Scorpion Group issued a scathing report about TransMedics Group. Scorpion has alleged that TransMedics committed healthcare fraud and that its OCS device "has no value ...

Scorpion Capital said in a newly-issued short report that in “20 years of shorting, TransMedics (TMDX) is the most extreme and grotesque healthcare fraud we have encountered, not only for its ...

On January 10, 2025, Bloomberg reported TransMedics shares dropped“as much as 13% after Scorpion Capital said it is short the transplant-therapy company's stock.” ...

TransMedics Group (NASDAQ:TMDX) experienced a sharp decline in its stock price today, falling over 15% following the release of a critical report by Scorpion Capital. The report accuses the company of ...

This should act as a reminder of the risks the industry faces. We sell different types of products and services to both investment professionals and individual investors. These products and ...